1Abbo KM, Dooris M, Glazier S, et al. Features and outcome of no-reflow after percutaneous coronary intervention. Am J Cardiol, 1995,75:778-782.
2Kloner RA, Ganote CE, Jennings RB. The “no-reflow” phenomenon after temporary coronary occlusion in the dog. J Clin Invest, 1974,54 : 1496-1508.
3Schofer J, Montz R, Mathey DG. Scintigraphic evidence of the “no reflow” phenomenon in human beings after coronary thrombolysis. J Am Coll Cardiol, 1985,5:593-598.
4Bates ER, Krell MJ, Dean EN, et al. Demonstration of the “no-reflow” phenomenon by digital coronary arteriography. Am J Cardiol, 1986,57 : 177-178.
5Eeckhout E, Kern MJ. The coronary no-reflow phenomenon : a review of mechanisms and therapies. European Heart Journal, 2001,22:729-739.
8Marzilli M, Orsini E, Marraccini P, et al. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation, 2000,101:2154-2159.
9Kelly RV, Cohen MG, Stouffer GA. Incidence and management of “no-reflow” following percutaneous coronary interventions. Am J Med Sci, 2005,329:78-85.
10Barcin C, Denktas A, Lennon RJ, et al. Comparison of combination therapy of adenosine and nitroprusside with adenosine alone in the treatment of angiographic no-reflow phenomenon. Cath Cardiovasc Interv, 2004,61:484-491.
2Ito H,Maruyama A,Iwakura K,et al.Clinical implications of the ‘no-reflow' phenomenon:a predictor of complications and left ventricular remodeling in perfused anterior wall myocardial infarction.Circulation 1996; 93:223-228.
3Gersh BJ.Optimal management of acute myocardial infarction at the down of the next millennium.Am Heart J 1999; 138 (2Pt2):188-202.
4Piana RN,Paik GY,Moscucci M,et al.Incidence and treat ment of "no-reflow" after percutaneous coronary intervention.1994;89:2514.
5Ito H,Tomooka T,Sakai N,et al.Lack of myocardial perfusion immediately after successful thrombolysis:a predictor of poor recovery of left ventricular function in anterior myocardial infarction.Circulation 1992; 85:1699-1705.
6Abbo KM,Dooris M,Glaziar S.Features and outcome of noreflow after percutaneous coronary intervention.Am J Cardiol 1995 ;75:778-82.
7Morshima J.Long term prognostic impact of angiographic noreflow phenomenon in patients treated with angioplasty for acute myocardial infarction possible involvement of left ventricular remodeling.Circulation 1999; 100(Suppl 1):451-456.
8Eeckhout E,Kern MJ.The coronary no-reflow phenomenon:a review of mechanism and therapies.Eur Heart J 2001; 22:729-739.
9Babbitt DG,Virmani R,Forman MB.Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model.Circulation 1989; 80(5):1388-1399.
10Nakae I, Takaoka A, Mitsunami K, et al. Cardioprotective effects of nicorandil in rabbits anaesthetized with halothane: Potentiation of ischaemic preconditioning via KAT Pchannels [J]. Clin-Exp- Pharmacol-Physiol. 2000,27(10):810～817.
